Thomas Cuisset1*, MD; Harald Mudra2, MD; Oliver Muller3, MD PhD; Pierre Vogt3, MD; Anne Angelillo-Scherrer4, MD; Kurt Huber5, MD
1. Department of Cardiology, University Hospital La Timone, Marseille, France; 2. Department of Cardiology, Pulmonology and Internal Intensive Care Medicine, Städtisches Klinikum München GmbH, Klinikum Neuperlach, Munich, Germany; 3. Cardiovascular Center
Recent European Society of Cardiology (ESC) Guidelines have extensively investigated antithrombotic therapy during percutaneous coronary interventions (PCI)1-3. However, based on the